In MCF-7 breast cancer cell line, HRG has been shown to increase a sustained mitogen-activated protein kinase (MAPK) signal activity favoring differentiation, whereas EGF only elicits a transient MAPK signal activity favoring cell proliferation [26, 27]. The gene discussed is WNK2; the disease is breast cancer.